LN0504739
98% , 1675248-19-7
| Pack Size | Price | Stock | Quantity |
| 100mg | RMB51997.60 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| storage temp. | Storage temp. 2-8°C |
| solubility | DMSO (Slightly), Methanol (Slightly) |
| form | Solid |
| color | Off-White to Pale Orange |
| InChI | InChI=1/C16H22N6O2/c1-10-4-6-22(14(24)7-13(17)23)8-12(10)21(2)16-11-3-5-18-15(11)19-9-20-16/h3,5,9-10,12H,4,6-8H2,1-2H3,(H2,17,23)(H,18,19,20)/t10-,12+/s3 |
| InChIKey | CRDMXSMPTHMXRD-OMRPPZTANA-N |
| SMILES | N([C@@H]1[C@@H](CCN(C(=O)CC(=O)N)C1)C)(C1N=CN=C2NC=CC=12)C |&1:1,2,r| |
Description and Uses
Tofacitinib impurity L is an impurity of Tofacitinib (T528000), an enantiopure stereoisomer of the drug, Janus kinase 3(Jak3) inhibitor (CP-690,550) that has been found to inhibit selected members of the STE7 and STE20 subfamily of kinases.
Safety
| Symbol(GHS) | ![]() GHS07 |
| Signal word | Warning |
| Hazard statements | H315-H319-H335 |
| Precautionary statements | P264-P280-P302+P352-P321-P332+P313-P362-P305+P351+P338-P337+P313-P261-P271-P304+P340-P312-P403+P233-P405-P501 |



![N-Methyl-N-((3S,4S)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine](https://img.chemicalbook.com/CAS/GIF/1260614-73-0.gif)

![N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine](https://img.chemicalbook.com/CAS/20180629/GIF/1092578-45-4.gif)

